Tom O’Bryan, DC, CCN, DACBN - Dietary Triggers of Pain and Inflammation (2016 Conference) (LDN, low dose naltrexone)

Download Dr. O'Bryan's Dietary Triggers Presentation

Pradeep Chopra, MD - Chronic Pain, Opioids and LDN (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Chopra's Pain Presentation

Paul Battle, PA-C - Crohn’s Disease (2016 Conference) (LDN, low dose naltrexone)

Download Paul Battle's Crohn's Presentation

Microbiome Medicine: Clinical Correlations From The Trenches - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

In her presentation, Dr. Zielsdorf shares the importance and complexity of the human microbiome and best practices (from her own clinical experience) for restoring the gut microbiome and intestinal barrier.

Infection - Stefanie Werner, NMD (2021 Conference) (LDN, low dose naltrexone)

SIBO - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Opiate Receptor Drugs – To Cycle or Not to Cycle Dosing? - Paul Anderson, NMD (2021 Conference) (LDN, low dose naltrexone)

Mold toxicity - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Restless Leg Syndrome - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

This lecture starts with the known and newer pathophysiology to try to uncover new ways of treating restless legs syndrome (RLS). Using case studies, he links RLS with small intestinal bacterial overgrowth (SIBO), low iron, and other autoimmune disorders. Treatment examples are provided

Atopic Dermatitis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Atopic dermatitis is a hereditary skin disorder, and the most common form of eczema. Dr. Smith reviews the pathophysiology and diagnostic criteria for atopic dermatitis, as well as some causes.